Shukra Pharmaceuticals Limited
SHUKRAPHAR
Rank in Stocks
#13524
Shukra Pharmaceuticals Limited is a prominent company engaged in the... Shukra Pharmaceuticals Limited is a prominent company engaged in the manufacturing and global distribution of pharmaceutical products. Their comprehensive product line addresses a broad spectrum of medical conditions, encompassing anti-infective medications (such as antibiotics, macrolides, quinolones, antivirals, antifungals, antimalarials, antiprotozoals, and anti-helminthics), central nervous system drugs (including sedatives, tranquilizers, antidepressants, and anti-manic agents), gastrointestinal treatments (like anti-emetics and anti-ulcer drugs), cardiovascular remedies (beta-blockers, diuretics), pain and inflammation management (analgesics, muscle relaxants, corticosteroids), anti-tuberculosis drugs, vitamin supplements, anti-allergy medications, and therapies for metabolic imbalances such as hyper- and hypoglycemia. The company was established on March 4, 1993, and its primary operations are directed from its headquarters in Ahmedabad, India.
Share Price
$0.87400294
Last synced: 2026-11-09
Market Cap
$384.22M
Change (1 day)
3.87%
Change (1 year)
85.37%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Shukra Pharmaceuticals Limited (SHUKRAPHAR)
Category
Healthcare
Operating Margin for Shukra Pharmaceuticals Limited (SHUKRAPHAR)
Operating Margin as of November 2026 TTM: 57.20%
According to Shukra Pharmaceuticals Limited's latest financial reports, its current operating margin (TTM) is 57.20%. At the end of 2025 the company had an operating margin of 29.84%.
Operating Margin history for Shukra Pharmaceuticals Limited from 2008 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 57.20% | 91.69% |
| 2025 | 29.84% | 28.23% |
| 2024 | 23.27% | 196.43% |
| 2023 | 7.85% | 30.18% |
| 2022 | 6.03% | 141.20% |
| 2021 | 2.50% | 380.77% |
| 2020 | 0.52% | -98.79% |
| 2019 | 42.87% | -17.02% |
| 2018 | 51.66% | 165.33% |
| 2017 | 19.47% | 394.16% |
| 2016 | 3.94% | -111.99% |
| 2015 | -32.87% | 61.92% |
| 2014 | -20.30% | 304.38% |
| 2013 | -5.02% | -116.31% |
| 2012 | 30.78% | 346.09% |
| 2011 | 6.90% | 107.21% |
| 2010 | 3.33% | 445.90% |
| 2009 | 0.61% | -134.86% |
| 2008 | -1.75% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 62.34% | -98.91% |
US
|
|
| 31.60% | -99.45% |
SE
|
|
| 30.13% | -99.47% |
FR
|
|
| 29.76% | -99.48% |
HK
|
|
| 30.46% | -99.47% |
IT
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Shukra Pharmaceuticals Limited's operating margin
What is Shukra Pharmaceuticals Limited's operating margin?
Shukra Pharmaceuticals Limited's operating margin is 57.20%, as of Nov 2026.
What was Shukra Pharmaceuticals Limited's operating margin in 2025?
In 2025, Shukra Pharmaceuticals Limited's operating margin was 29.84%, compared with 23.27% in 2024.
How has Shukra Pharmaceuticals Limited's operating margin changed since 2020?
From 2020 to 2025, Shukra Pharmaceuticals Limited's operating margin was highest in 2025 (29.84%) and lowest in 2020 (0.52%).
How does Shukra Pharmaceuticals Limited's operating margin compare with similar companies?
Shukra Pharmaceuticals Limited's operating margin (57.20%) is higher than that of 4 of the 5 similar companies listed above. The highest among them is Royalty Pharma plc, with 62.34%.